IDH2 and cholangiocarcinoma: In this study we incorporated DNA methylation data from Cancer Genome Atlas (TCGA) profiled IDH mutant and wild-type acute myeloid leukemia (AML, N = 21)6 and cholangiocarcinoma (N = 9)11.